Emergent Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
1,506
-246
-14% -$28.8K 0.11% 117
2026
Q1
$211K Sell
1,752
-514
-23% -$59.3K 0.12% 120
2025
Q4
$239K Sell
2,266
-662
-23% -$62.1K 0.13% 118
2025
Q3
$246K Buy
+2,928
New +$241K 0.14% 105
2025
Q1
Sell
-5,051
Closed -$502K 117
2024
Q4
$502K Buy
5,051
+35
+0.7% +$3.61K 0.36% 53
2024
Q3
$570K Buy
5,016
+343
+7% +$40.8K 0.42% 44
2024
Q2
$590K Buy
4,673
+1,143
+32% +$147K 0.47% 41
2024
Q1
$466K Sell
3,530
-38
-1% -$4.68K 0.4% 48
2023
Q4
$389K Buy
+3,568
New +$370K 0.36% 54

Other funds holding MRK

Emergent Wealth Advisors's MRK Position: Q2 2026 in Review

Emergent Wealth Advisors reduced its Merck (MRK) stake by 14% in Q2 2026, selling an estimated $28.8K and leaving 1,506 shares worth $209K. The position accounts for 0.11% of the portfolio, ranked #117.

Emergent Wealth Advisors first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $590K in Q2 2024. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Emergent Wealth Advisors held 1,506 shares of Merck worth $209K as of Q2 2026.
  • Emergent Wealth Advisors sold 246 Merck shares in Q2 2026, an estimated $28.8K.
  • Merck made up 0.11% of Emergent Wealth Advisors's portfolio in Q2 2026, its #117 holding.
  • Emergent Wealth Advisors first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • Emergent Wealth Advisors's Merck position peaked at $590K in Q2 2024.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Emergent Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.